Gilead PAP Changes
What is Changing: Implementation Extended to January 31, 2025: Effective January 31, 2025, Gilead’s Patient Assistance Programs (PAPs), including Advancing Access, will stop providing free medications for medicines where there…
Bristol-Myers Squibb Sues To Implement Rebate Model; AbbVie Adds Grantees To Its Contract Pharmacy Policy
Bristol-Myers Squibb Sues HHS To Implement 340B Rebate Model On November 26, 2024, Bristol-Myers Squibb (BMS) filed a lawsuit against HRSA in the D.C. District Court to defend its proposed…
Sanofi Announces Rebate Model; All Eyes on Whether HHS Will Threaten to Terminate It from Medicaid and Medicare
On November 25, 2024, Sanofi became the third manufacturer to announce its intention to implement a rebate model. Its announcement follows similar announcements from Johnson & Johnson (J&J) and Eli…
Third Lawsuit Is Filed Against HRSA for Blocking the Rebate Model
11/19/2024 – Third Lawsuit Is Filed Against HRSA for Blocking the Rebate Model On November 14, 2024, Eli Lilly and Company (Lilly) filed a lawsuit against HHS and HRSA in…
J&J Sues HHS and HRSA Over HRSA’s Opposition to J&J’s Proposed Rebate Model
11/14/2024 – J&J Sues HHS and HRSA Over HRSA’s Opposition to J&J’s Proposed Rebate Model On November 12, 2024, Johnson and Johnson Health Care System Inc. (J&J) filed a lawsuit…
Boehringer Ingelheim Will Require Claims Data Submission for Single Contract Pharmacy
11/5/2024 – Beginning December 2, 2024, Boehringer Ingelheim Pharmaceuticals, Inc. (BI) will require covered entities to submit 340B claims data to 340B ESP™ for a single contract pharmacy. This policy applies…
VP of Pharmacy for Positive Impact Health Centers Emily Blaiklock on 340B Generic Drug Program for Rural/Ryan White Clinics WOYM 10-4
VP of Pharmacy for Positive Impact Health Centers Emily Blaiklock on 340B Generic Drug Program for Rural/Ryan White Clinics WOYM 10-4, listen to the interview here: https://wlds.com/audio/vp-of-pharmacy-for-positive-impact-health-centers-emily-blaiklock-on-340b-generic-drug-program-for-rural-ryan-white-clinics-woym-10-4/
J&J Will No Longer Offer Up-Front 340B Discounts to DSH CEs for Stelara and Xarelto; Drugmaker Unilaterally Imposing Rebate Model
Johnson & Johnson Health Care System Inc. (J&J) announced last week that, effective October 15, 2024, disproportionate share hospital (DSH) covered entities will no longer have access to up-front 340B…
Medicare to Cover PrEP and Associated Services Under Part B Only
CMS announced that it expects to release a final National Coverage Determination (NCD) late next month that will move the PrEP coverage benefit from Medicare Part D to Medicare Part…
Alkermes and Viatris Impose 340B Program Contract Pharmacy Restrictions
Alkermes and Viatris have become the 36th and 37th manufacturers, respectively, to impose restrictions on contract pharmacy arrangements. These restrictions are effective July 22 and August 1, respectively, but please…